BR9711605A - Bis-indolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo de c-lula - Google Patents

Bis-indolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo de c-lula

Info

Publication number
BR9711605A
BR9711605A BR9711605A BR9711605A BR9711605A BR 9711605 A BR9711605 A BR 9711605A BR 9711605 A BR9711605 A BR 9711605A BR 9711605 A BR9711605 A BR 9711605A BR 9711605 A BR9711605 A BR 9711605A
Authority
BR
Brazil
Prior art keywords
indolylmaleimides
inhibition
bis
substituted
cell proliferation
Prior art date
Application number
BR9711605A
Other languages
English (en)
Portuguese (pt)
Inventor
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9711605A publication Critical patent/BR9711605A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9711605A 1996-07-29 1997-07-19 Bis-indolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo de c-lula BR9711605A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
PCT/EP1997/003889 WO1998004552A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (1)

Publication Number Publication Date
BR9711605A true BR9711605A (pt) 1999-08-24

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711605A BR9711605A (pt) 1996-07-29 1997-07-19 Bis-indolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo de c-lula

Country Status (23)

Country Link
US (2) US5856517A (enExample)
EP (1) EP0915872B1 (enExample)
JP (1) JP2000516589A (enExample)
KR (1) KR20000029637A (enExample)
CN (2) CN1495182A (enExample)
AR (1) AR008267A1 (enExample)
AT (1) ATE240318T1 (enExample)
AU (1) AU739742B2 (enExample)
BR (1) BR9711605A (enExample)
CA (1) CA2262092A1 (enExample)
CO (1) CO4900055A1 (enExample)
CY (1) CY2483B1 (enExample)
DE (1) DE69722003T2 (enExample)
DK (1) DK0915872T3 (enExample)
ES (1) ES2198001T3 (enExample)
HR (1) HRP970414A2 (enExample)
MA (1) MA24287A1 (enExample)
PE (1) PE91698A1 (enExample)
PT (1) PT915872E (enExample)
SA (1) SA97180473A (enExample)
TR (1) TR199900157T2 (enExample)
WO (1) WO1998004552A1 (enExample)
ZA (1) ZA976492B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2208612C2 (ru) * 1998-03-17 2003-07-20 Ф.Хоффманн-Ля Рош Аг Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
WO2001044235A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
EP1242420A2 (en) * 1999-12-16 2002-09-25 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) * 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
WO2006086484A1 (en) 2005-02-09 2006-08-17 Arqule, Inc. Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
EP2170870B1 (en) 2007-06-22 2014-03-05 ArQule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
US6030994A (en) 2000-02-29
TR199900157T2 (xx) 1999-04-21
ZA976492B (en) 1998-01-29
DE69722003D1 (de) 2003-06-18
CN1226247A (zh) 1999-08-18
SA97180473A (ar) 2005-12-03
PE91698A1 (es) 1998-12-24
AU739742B2 (en) 2001-10-18
CN1495182A (zh) 2004-05-12
JP2000516589A (ja) 2000-12-12
EP0915872A1 (en) 1999-05-19
KR20000029637A (ko) 2000-05-25
CY2483B1 (en) 2005-06-03
HRP970414A2 (en) 1998-06-30
US5856517A (en) 1999-01-05
DE69722003T2 (de) 2004-04-01
EP0915872B1 (en) 2003-05-14
MA24287A1 (fr) 1998-04-01
ES2198001T3 (es) 2004-01-16
CN1151149C (zh) 2004-05-26
CA2262092A1 (en) 1998-02-05
AU3769097A (en) 1998-02-20
WO1998004552A1 (en) 1998-02-05
ATE240318T1 (de) 2003-05-15
AR008267A1 (es) 1999-12-29
PT915872E (pt) 2003-09-30
CO4900055A1 (es) 2000-03-27
DK0915872T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
BR9711605A (pt) Bis-indolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo de c-lula
BR9711607A (pt) Bisindolilmaleimidas substitu¡das para a inibi-Æo de prolifera-Æo celular
BR9709474A (pt) Instalação para compensador sincrono
NO972270L (no) Vannfortynnbart beleggingsmateriale for korrosjonsbeskyttelse
NO985966D0 (no) Celleadhesjonsinhiberende forbindelser
DE69712625D1 (de) Austragsvorrichtung
DE69721231D1 (de) Anisotrop leitende zusammensetzung
PT1113965E (pt) Acessorio para gargalo de garrafa
DE69700310D1 (de) Rostschutzzusammensetzung
DK0795717T3 (da) Kondensatudledningsindretning
DE59706429D1 (de) Biegerichtmaschine
ID17561A (id) Komposisi untuk pemakaian luar
BR9710134A (pt) Separadores de fibra de vidro para baterias
BR9710385A (pt) Triazoloazinossulfonamidas substitu¡das
DE69717943D1 (de) Austragvorrichtung
BR9710902A (pt) Bisindolilmaleimidas substituidas para a inibi-Æo de prolifera-Æo de celulas
NO990116L (no) Korrosjonsinhibering
BR9703562A (pt) Composiçoes para tratamento de água
DE59805196D1 (de) Silo für schlämme
NO964898D0 (no) Elektrokjemisk anlegg
PT1027278E (pt) Torneira para distribuicao de liquidosiq
DE69722799D1 (de) Zellzusammenstellungen
NO964439L (no) Fôr
NO991735D0 (no) Vaskemiddelblanding
ID19891A (id) Komposisi gangguan peredaran anti-okular

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT. CL. 7: C07D403/14, A61K 31/40

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO DE ACORDO COM O ART. 8O DA LPI.